APLN and endothelial dysfunction: Apelin/APJ has been demonstrated to be involved in the development of hypercholesterolemia-associated atherosclerosis similarly to angiotensin II/AT1, which promotes endothelial dysfunction and myosin light chain phosphorylation in VSMCs [48,49,50,51].